Activated Hemostatic Biomarkers in Patients with Implanted Left Ventricle Assist Devices: Are Heparin and/or Clopidogrel Justified?

Publisher： Karger

E-ISSN： 1421-9751|131|3|172-176

ISSN： 0008-6312

Source： Cardiology, Vol.131, Iss.3, 2015-05, pp. : 172-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sulcus subarachnoid hemorrhage is a common stroke subtype in patients with implanted left ventricular assist devices

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 7, 2015-07 ,pp. : 1088-1093

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices

By  

PACING AND CLINICAL ELECTROPHYSIOLOGY, Vol. 38, Iss. 8, 2015-08 ,pp. : 925-933

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transcatheter aortic valve repair for management of aortic insufficiency in patients supported with left ventricular assist devices

By  

JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol. 31, Iss. 10, 2016-10 ,pp. : 654-657

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticoagulation management of left ventricular assist devices

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 175-178

John Wiley & Sons Inc

Access to resources Recommend Favorite

Left Ventricular Assist Devices: From the Bench to the Clinic

By  

Cardiology, Vol. 125, Iss. 1, 2013-04 ,pp. : 1-12

Karger

Access to resources Recommend Favorite